CXCR4-directed endoradiotherapy with 177LuPentixather added to total body irradiation for myeloablat...
CXCR4-directed endoradiotherapy with 177LuPentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia
About this item
Full title
Author / Creator
Braitsch, Krischan , Lorenzini, Theo , Hefter, Maike , Koch, Katrin , Nickel, Katharina , Peeken, Jan C , Götze, Katharina S , Weber, Wolfgang , Allmann, Anne , D'Alessandria, Calogero , Brosch-Lenz, Julia , Bassermann, Florian , Rudelius, Martina , Verbeek, Mareike , Eiber, Matthias and Herhaus, Peter
Journal title
Language
English
Formats
More information
Scope and Contents
Contents
Rationale: Despite recent advances in the targeted therapy of AML, the disease continues to have a poor prognosis. Allogeneic hematopoietic stem cell transplantation (alloSCT) remains to be the curative therapy option for fit patients with high-risk disease. Especially patients with relapsed or refractory (r/r) AML continue to have poor outcomes. M...
Alternative Titles
Full title
CXCR4-directed endoradiotherapy with 177LuPentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3150838256
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3150838256
Other Identifiers
ISSN
1838-7640
E-ISSN
1838-7640
DOI
10.7150/thno.101215
